Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination
Running, not enrolling · Not applicable
Conditions studied: Parents
In brief
This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection. A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.
Key facts
- Study ID
- NCT03209713
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 672
- Starts
- 2017-06-28
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-04-22
Who can join
Age: 21 and older, up to 84. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Born in Mexico or born in U.S. but self-describes as Mexican-American
- Spanish is his or her primary language
- Has a minimum of one child between the ages of 11 and 17 who has not initiated or completed the HPV vaccine seriest (as per the age-recommended timeframe)
- Self-identifies as the child's main caregiver
- Currently owns a cell phone and uses text messaging services and is willing to accept text messages for this study
- 21 to 84 years old
You may not qualify if…
- Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional's judgment.
Where it is running
- Alivio Medical Center — Chicago, Illinois, United States
- Research, Education and Access to Community Health (REACH) — Las Vegas, Nevada, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- The University of Texas at El Paso — El Paso, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.